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While viral infections and their impact are well studied in domestic cats, only limited information is
available on their occurrence in free-ranging lions. The goals of the present study were (i) to investigate the
prevalence of antibodies to feline calicivirus (FCV), herpesvirus (FHV), coronavirus (FCoV), parvovirus (FPV),
and immunodeficiency virus (FIV) and of feline leukemia virus (FeLV) antigen in 311 serum samples collected
between 1984 and 1991 from lions inhabiting Tanzania’s national parks and (ii) to evaluate the possible
biological importance and the interrelationship of these viral infections. Antibodies to FCV, never reported
previously in free-ranging lions, were detected in 70% of the sera. In addition, a much higher prevalence of
antibodies to FCoV (57%) was found than was previously reported in Etosha National Park and Kruger
National Park. Titers ranged from 25 to 400. FeLV antigen was not detectable in any of the serum samples.
FCoV, FCV, FHV, and FIV were endemic in the Serengeti, while a transient elevation of FPV titers pointed to
an outbreak of FPV infection between 1985 and 1987. Antibody titers to FPV and FCV were highly prevalent
in the Serengeti (FPV, 75%; FCV, 67%) but not in Ngorongoro Crater (FPV, 27%; FCV, 2%). These differences
could be explained by the different habitats and biological histories of the two populations and by the
well-documented absence of immigration of lions from the Serengeti plains into Ngorongoro Crater after 1965.
These observations indicate that, although the pathological potential of these viral infections seemed not to be
very high in free-ranging lions, relocation of seropositive animals by humans to seronegative lion populations
must be considered very carefully.
The most important viruses of domestic cats are feline cali-
civirus (FCV), feline herpesvirus (FHV), feline parvovirus
(FPV), feline coronavirus (FCoV), feline leukemia virus
(FeLV), and feline immunodeficiency virus (FIV). While these
viruses are well studied in domestic cats, much less is known
about their prevalence and importance in free-ranging lions
(43, 44).
As no information is available on the occurrence of FCV,
FHV, FPV, FCoV, and FeLV in lions of East Africa, it was the
aim of the present study to investigate the prevalence of these
infections in some lion populations living in Tanzania’s na-
tional parks. In order to elucidate the possible importance of
these infections in lions, essential features of these viruses are
addressed briefly below.
FCoV occurs worldwide in domestic cats. Some isolates of
FCoV are known to induce feline infectious peritonitis, while
others cause very mild to fatal enteritis. Feline infectious peri-
tonitis has been recognized not only in domestic cats but also
in captive cheetahs, jaguars, lions, mountain lions, and leop-
ards (9, 10, 16, 38, 40, 50, 51, 53). Cheetahs were found to be
dramatically susceptible to FCoV-mediated pathology, per-
haps a consequence of genetic homogenization of the immune
response in that species (12, 31). FCoV have been isolated
from cheetahs that died during an epizootic at Wildlife Safari
in Winston, Oreg. (11, 12, 38). Smaller wild felids kept in
captivity, such as lynx, caracal, sand cat, serval, and pallas cat,
have also been infected with FCoV (37, 39, 47, 53). In the
populations of free-ranging mountain lions in California, ap-
proximately one-third of the animals had antibodies to FCoV
(36), while none of the lions in Kruger National Park and only
3% of the lions in Etosha National Park were FCoV positive
(43, 44).
FHV and FCV are agents causing mainly upper respiratory
tract diseases. FHV causes rhinotracheitis and is therefore also
referred to as feline viral rhinotracheitis virus; FCV in most
instances is responsible for stomatitis, gingivitis, and circum-
script lesions of the tongue. Clinical signs of rhinotracheitis
have been described in captive cheetahs, jaguars, leopards, and
mountain lions (3, 47, 48). Infectious agents were isolated from
these animals and from a captive lion and characterized as
FHV on the basis of typical cytopathic effect in cell culture,
results of a neutralization assay, and appearance under an
electron microscope (3, 48, 49). Most free-ranging lions had
antibodies to FHV (67% in Etosha National Park, 91% in
Kruger National Park), but none of them had antibodies to
FCV (43, 44), while approximately one-fifth of the sera from
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thurerstr. 260, CH-8057 Zurich, Switzerland. Phone: 41 1 635 83 22.
Fax: 41 1 635 89 06. Electronic mail address: rhofmann@vetklinik
.unizh.ch.
554
 o
n
 February 3, 2016 by NO
VA SO
UTHEASTERN UNIV
http://cvi.asm
.org/
D
ow
nloaded from
 
free-ranging mountain lions in California had antibodies to
FHV and/or FCV (36).
FPV is highly contagious, inducing an acute disease charac-
terized by leukopenia, fever, depression, dehydration, and di-
arrhea in domestic cats. In unvaccinated populations it has a
high mortality rate. All members of the family Felidae are
believed to be susceptible to FPV. In 1964, Johnson reported
the isolation of feline panleukopenia virus from the spleen of
a leopard cub born at Bristol Zoo (20). Subsequently, FPV was
isolated from dead captive lions, panthers, snow leopards, and
tigers (46, 47). The majority of the free-ranging mountain lions
in California (93%) and the lions in Kruger National Park
(84%) had antibodies to FPV (36, 43), while none of the
free-ranging lions in Etosha National Park did (44). It was
suspected that the lions in Kruger National Park had been
infected by domestic cats, introduced some years earlier. How-
ever, the lions were not tested prior to this (43).
FIV infection is associated with immune suppression and
opportunistic infections in domestic cats. FIV occurs world-
wide in domestic cats. Antibodies to FIV have also been found
in various zoo-kept wild felids (2, 5, 25). In addition, antibodies
to FIV were detectable in cheetahs inhabiting East Africa, but
not South or West Africa, in free-ranging pumas and bobcats
inhabiting North America, and in leopards from Kruger Na-
tional Park (2, 5, 33). FIV was found to be highly prevalent in
free-ranging lions in East Africa (5, 33) and in Kruger National
Park but not in India or Etosha National Park (5, 22, 25, 33).
Lentiviruses, which are closely related to the immunodefi-
ciency virus of domestic cats, were isolated from pumas and
lions (6, 33). However, much less is known about the patho-
genicity and the biologic importance of the immunodeficiency
virus in lions.
FeLV is known to cause neoplastic diseases and more fre-
quently leads to an immunosuppression in domestic cats (15,
18). FeLV infection so far has never been described in free-
ranging wild felids, with the exception of two confirmed re-
ports: (i) two FeLV-positive European wild cats (Felis silvestris)
trapped in northern Scotland that apparently caught the infec-
tion in the wild, however from an uncertain source (4), and (ii)
a wild FeLV-positive cougar (Felis concolor), removed from a
Californian college campus, which had supposedly preyed on
domestic cats potentially infected with FeLV (19). Neverthe-
less, a serological survey in free-ranging mountain lions did not
reveal any further evidence of exposure to FeLV (36).
It was the goal of the present study to determine prevalence
and possible biological importance of these viral infections in
free-ranging lions living on the Serengeti plains, near Lake
Manyara, and in Ngorongoro Crater.
MATERIALS AND METHODS
Between 1984 and 1991, 311 serum samples were collected from free-ranging
East African lions (Panthera leo) inhabiting Tanzania’s Serengeti National Park
(n5 255), Ngorongoro Crater (n5 51), and the Lake Manyara area (n5 5) (Fig.
1). Twenty-four lions in Serengeti National Park and six animals from Ngor-
ongoro Crater were sampled twice on different dates. The sera were stored at
2208C. These serum samples had been collected by a team of researchers under
the supervision of one of us (Craig Packer). Other results obtained from these
sera were reported elsewhere (33). All sera were examined for the presence of
antibodies to FCoV, FHV, FCV, FPV, and FIV and for the presence of FeLV
antigen. Serological data were examined with respect to habitat, sex, and age of
lions and year of blood collection.
Detection of antibodies to FCoV. Antibodies against FCoV were detected by
FIG. 1. Maps of Africa (left; scale approximately 1:105,000,000) and of Tanzania’s National Parks (right; scale approximately 1:2,100,000). Serum samples were
collected from lion populations inhabiting Serengeti National Park, Ngorongoro Crater, and Lake Manyara National Park. Numbers in parenthesis indicate the number
of samples collected. In addition, Etosha National Park in Namibia and Kruger National Park in South Africa are indicated.
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immunofluorescence assay (IFA), as described previously (24, 34), with trans-
missible gastroenteritis virus (Purdue strain). Serum samples were tested at
dilutions of 1:25, 1:100, 1:400, and 1:1,600.
Detection of antibodies to FCV. Antibodies to FCV were detected by enzyme-
linked immunosorbent assay (ELISA) and by IFA. CRFK cell monolayers were
infected with FCV (strain 227/62) (7) and incubated until cytopathic effect
reached about 60% of the cells. At the same time, mock-infected cells were
grown and handled in an identical manner. Infected and mock-infected cells
were scraped with a rubber policeman and lysed in Tris-sodium chloride con-
sisting of 25 mM Tris-HCl, pH 8.2, and 150 mM sodium chloride, on ice, for 15
min. The lysates were treated with 0.1 M glycine-saline buffer (pH 9.0) at 10%
lysate volume and incubated for 30 min at 378C. Crude antigens were subjected
to low-speed centrifugation at 1,250 3 g at 48C for 30 min. ELISA plates were
coated with 100 ng of these antigens, diluted in coating buffer, per well (26).
Serum samples were diluted 1:100 and tested by ELISA as described previously
(26). As a conjugate, peroxidase-labelled rabbit anti-cat immunoglobulin G
(Nordic Immunologic Laboratories, Tillburg, The Netherlands) diluted 1:2,000
was used. The results were given as the difference in optical density (dOD)
between FCV-infected cells and mock-infected cells. The same antigens were
used for the IFA by the procedure described for FCoV with a modified serum
dilution (1:10, 1:20, 1:40, 1:80, and 1:160).
Detection of antibodies to FHV. Antibodies to FHV were detected by ELISA
and by IFA. CRFK cell monolayers were infected with FHV (CH strain) and
incubated for 4 days. Mock-infected cells were grown at the same time and
handled in the same manner. Cells were washed with phosphate-buffered saline
(PBS) and placed on ice. Lysis buffer (50 mM Tris-HCl [pH 7.4], 100 mM NaCl,
5 mMEDTA, 1%Nonidet P-40, 0.5% deoxycholic acid sodium salt, 0.1% sodium
dodecyl sulfate) was added, and cells were scraped with a rubber policeman. A
protease inhibitor cocktail containing 0.11 mM phenylmethylsulfonyl fluoride
and 0.10 mM iodoacetamide was added for a further 15 min. When the suspen-
sions were homogeneous, glycerol was added to a final concentration of 10% and
the mixtures were allowed to stand overnight at 48C. After centrifugation at
1,750 3 g at 48C for 20 min, supernatants were collected and dialyzed against 10
mM Tris-HCl (pH 7.4) containing 150 mM NaCl for 24 h at 48C. The antigens
were aliquoted and stored at2208C. The antigens were used for the ELISA (100
ng per well) and the IFA in the procedure described for FCV. In addition, 40
sera were tested by immunoblotting (Western blotting) with FHV-infected
CRFK cells and mock-infected CRFK control cells according to procedures
described previously for other antigens (23). The optimal amount of antigen per
strip was determined previously by serial dilution of infected cell lysates.
Detection of antibodies to FPV. Antibodies to FPV were detected by a hem-
agglutination inhibition assay. Test and control sera were heat inactivated at
568C for 30 min and treated with kaolin under conditions described previously
(42) in order to eliminate nonspecific agglutinins. Samples were diluted in mi-
crotiter V-form wells in serial twofold dilution in 0.2 M glycine buffer (pH 9.0)
starting at a dilution of 1:10. Serum dilutions (25 ml) were mixed with equal
volumes of a FPV suspension containing four hemagglutination units. The virus
was previously cultured on CRFK cells, frozen until use, and pretitrated the same
day. Mixtures were incubated for 1 h at room temperature. Swine erythrocytes
from sodium citrate-blood were washed with PBS three times. A suspension
containing 1% erythrocytes was made in phosphate-borate buffer (pH 7.0) (15
mmol of NaCl, 11.1 mmol of Na2HPO4, 9 mmol of KH2PO4 made up to 1 liter
with H2O, pH 6.7, mixed 1:1 with 150 mmol of NaCl, 50 mmol of H3BO3 made
up to 1 liter with H2O, pH 9.4). Of this suspension, 50 ml was added to each well,
and plates were incubated for 90 min at room temperature. Antibody titers were
read as the reciprocal of the endpoint dilution at which no erythrocyte aggluti-
nation was shown.
Detection of antibodies to FIV. Antibodies to FIV were detected by the
Western blot technique as described previously (5).
Detection of FeLV antigen. FeLV p27 antigen in the serum was assayed by a
double-antibody sandwich ELISA as described previously (27).
Statistical methods. Frequencies were compared by means of the two-tailed
chi-square test with Yates’ continuity correction, and multivariate analyses of
seroprevalence were performed by logistic regression. Differences were consid-
ered significant at P , 0.05. Data on coinfection include only one sample from
each individual.
RESULTS
All results were analyzed with respect to habitat, sex, and
age of lions and year of blood collection. No difference was
found unless specifically stated.
Prevalence of antibodies to FCoV. All 311 serum samples
were analyzed by the IFA to detect antibodies to FCoV. Forty-
three percent of the lions had no detectable antibodies to
FCoV, 50% of the animals had a titer of 25, 23 lions (7.4%)
had a titer of 100, and the serum of one animal, a male lion
originating from Serengeti National Park, yielded a titer of
400. Antibodies to FCoV were highly correlated with antibod-
ies to FIV (P 5 0.0014 [Table 1]).
Prevalence of antibodies to FCV. The serum samples were
analyzed by ELISA to detect antibodies to FCV (n 5 310). A
significant difference was found to be related to the origin of
the serum samples (P , 0.00001): the majority of the lions in
Ngorongoro Crater (82%) and all lions from the Lake Man-
yara area showed no antibodies with reactivity to FCV (dOD5
0). Only nine serum samples collected in Ngorongoro Crater
yielded a dOD.0. In contrast, 82% of the sera from Serengeti
National Park produced antibodies to FCV (Fig. 2). The prev-
alence of antibodies to FCV characterized by a dOD.0.100 in
the lions of Serengeti National Park increased with the age of
the lions (P , 0.0001 [Fig. 3]). Furthermore, the dOD in-
creased with increasing age of the lions (P , 0.0001; data not
shown). In addition, 95 of the sera were analyzed by IFA. The
results showed good agreement with the ELISA results (data
not shown). Sera with a high dOD showed a specific fluores-
cence up to a dilution of 1:40. The presence of antibodies to
FCV correlated with the presence of antibodies to FPV (P ,
0.0001, even controlling for habitat and age of the lions [Table
2]). In addition, there was a strong relationship between anti-
bodies to FCV and antibodies to FIV (Table 1). However,
when the statistical analysis was corrected for age of the lions,
this relationship disappeared: the relationship in animals
younger than 3 years was not significant (P 5 0.0903).
Prevalence of antibodies to FHV. When tested by ELISA,
antibodies to FHV were found in all samples except one (n 5
310). The frequency distribution of the antibodies from lions
from Serengeti National Park resembled a normal distribution,
TABLE 1. Relationship between antibodies to FIV and antibodies to the other four feline viruses tested
FIV
antibody
status
No. of sera positive or negative for antibody to:
FCV FPV FHV FCoV
Negative Positivea Negative Positiveb Negative Positivec Negative Positived
Negative 13 5 10 8 0 18 15 4
Positivee 95 149 86 157 1 243 94 150
Yates x2 6.35 2.13 0.149 10.26
pchi 0.0117 NS
f NS 0.0014
a ELISA dOD .0.100.
b Hemagglutination titer .10.
c ELISA dOD .0.
d IFA titer $25.
eWestern blot positive.
f NS, not significant.
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with a maximum dOD between 0.4 and 0.5. In contrast, the
sera from Ngorongoro Crater showed two maxima at a dOD of
0.3 to 0.4 and at a dOD of 0.7 to 0.8 (data not shown). The
dOD increased with increasing age of the lions (P , 0.0001;
data not shown). All sera tested by IFA (n 5 28) were positive
at a serum dilution of 1:10. Some of the sera showed the
specific fluorescence up to a dilution of 1:40. These sera were
predominantly sera which had a high dOD in the ELISA. Two
FIG. 2. Frequency distribution of antibodies to FCV detected by ELISA. The dOD indicates the difference in optical density yielded by antigen harvested from
FCV- and mock-infected cell cultures. Lions are grouped by habitat. In Serengeti National Park, a significantly higher number of lions had antibodies to FCV than did
lions in Ngorongoro Crater (P , 0.00001).
FIG. 3. Proportion of FCV-seropositive lions characterized as having an ELISA dOD of .0.1, grouped by age (in years). Numbers along the curve indicate the
numbers of samples analyzed. Prevalence of FCV in lions of Serengeti National Park increased significantly with age (P , 0.0001).
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sera with a high dOD even tested positive when diluted 1:80.
Western blotting resulted in the bands characteristic for FHV
(13) when FHV-infected cells were incubated with ELISA-
positive lion sera but not when mock-infected cells were incu-
bated. These bands had molecular sizes of approximately 110,
75, 60, 50, 36, 33, 19, 16, and 14 kDa and corresponded well
with the virus proteins vp5, vp7/8, vp9, vp12/13, vp18, vp19,
vp21, vp22, and vp23 (13).
Prevalence of antibodies to FPV. Antibodies to FPV were
detectable in 209 of 309 samples (68%) in the hemagglutina-
tion inhibition test. The titers ranged from 20 to .10,240. Low
titers (,160) were found in 55% of all lions, while higher titers,
which were found to correlate with protection in vaccinated
domestic cats, were detected in 45% of the tested animals. A
significant difference was related to the habitat of the lions
(P , 0.00001 [Fig. 4]): animals with high titers ($160) origi-
nated predominantly in Serengeti National Park (134 of 138
lions); only one lion from Ngorongoro Crater had an antibody
titer of 160, and all other samples yielded lower titers. A shift
of titers was found when the data were analyzed according to
the year of sample collection (P , 0.00001 [Fig. 5]). In Ngor-
ongoro Crater, no increase in the number of lions with high
titers could be detected during the observation period. How-
ever, the one sample from a lion inhabiting Ngorongoro Crater
which yielded a titer of 160 was collected in 1985. The five
samples originating from lions in the Lake Manyara region had
titers ranging from,10 to 5,120 and were all collected in 1987.
A decline in titers was found when the data were analyzed
according to the age of the lions (P , 0.0001; data not shown).
However, prevalence increased slightly with increasing age
(P 5 0.0248; data not shown).
Prevalence of antibodies to FIV. Antibodies to FIV were
found in 93% of the 44 sera tested from Ngorongoro Crater
and in 91% of the 243 tested sera from lions inhabiting
Serengeti National Park. No significant differences were re-
lated to sex or habitat of the animals. The virus was endemic.
There was no measurable interaction between antibodies to
FIV and the titer or the prevalence of antibodies to FPV and
FHV (Table 1). However, antibodies to FIV were significantly
more frequent in FCV-seropositive lions than in FCV-seroneg-
ative lions (P 5 0.0177) and were more frequent in FCoV-
seropositive animals than in lions without antibodies to FCoV
(P5 0.0014; see above). The FIV status had no apparent effect
on the lion’s survival.
Prevalence of FeLV antigen. FeLV antigen was detected in
none of the 311 serum samples tested.
DISCUSSION
The aim of this study was to investigate the prevalence and
importance of several feline viruses in free-ranging lions in-
FIG. 4. Frequency distribution of antibody titers to FPV detected in a hemagglutination inhibition test. Lions were grouped by habitat. In Serengeti National Park,
a significantly higher number of lions had high antibody titers to FPV ($160) than did lions in Ngorongoro Crater (P , 0.00001). Lions from Lake Manyara National
Park had titers up to 5,120 (data not shown).
TABLE 2. Relationship between antibodies to FCV
and antibodies to FPV
FPV antibody
status
No. of sera positive or negative
for FCV antibody
Negative Positivea
Negative 80 34
Positiveb 22 135
Yates x2 6.35
pchi ,0.00001
a ELISA dOD .0.100.
b Hemagglutination titer .10.
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habiting East Africa. Different serologic methods were used,
such as ELISA, IFA, hemagglutination, and Western blot tech-
nique, in order to detect antibodies to FCV, FHV, FPV,
FCoV, and FIV. FeLV antigen was measured by a sandwich
ELISA. Serological data were examined with respect to habitat
and sex of the lions and the year of blood collection.
High prevalence and titers of antibodies to FCoV. The IFA
used in this study to detect FCoV allows specific fluorescence
to be clearly distinguished from nonspecific signals as both
infected and noninfected cells were present on the slide. The
prevalence found in these lions (57%) is in accord with the
situation we see in domestic cats. No sex predisposition was
seen. This result is also analogous to the situation found in
domestic cats (1). The prevalence and the titers found were
much higher than the previously reported prevalence and titers
for free-ranging lions in other African national parks (43, 44)
(Table 3, Fig. 1). In fact, the earlier studies reported antibodies
to FCoV in none of the lions inhabiting Kruger National Park
(43) and in only 3% of the lions in Etosha National Park (45).
Whether these differences are due to assay conditions different
from ours is unknown. Spencer and coworkers also used an
IFA (43, 44). However, no information about the source and
FIG. 5. Frequency distribution of antibody titers to FPV detected in a hemagglutination inhibition test with serum samples from lions inhabiting Serengeti National
Park. Samples are grouped by year of collection. A shift of titers was found: increased titers in 1985 and 1986 and a decline thereafter.
TABLE 3. Comparison of the seroprevalence of FCV, FPV, FHV, FCoV, and FIV and of the prevalence of FeLV antigen in
free-ranging lions from different parts of Africa
Area
No. of sera positive/no. tested for:
FCV FPV FHV FCoV FIV FeLV antigen
East Africa
Serengeti National Park 170/254 (67%)a 192/253 (75%)b 252/253 (99%)c 149/254 (58%)d 221/243 (91%)e 0/255 (0%) f
Ngorongoro Crater 1/51 (2%)a 14/51 (27%)b 51/51 (100%)c 28/51 (55%)d 41/44 (93%)e 0/51 (0%) f
Lake Manyara region 0/5 (0%)a 3/5 (60%)b 5/5 (100%)c 1/5 (20%)d 4/5 (80%)g 0/5 (0%) f
South Africa (Kruger National Park) 0/32 (0%)h 27/32 (84%)h 29/32 (91%)h 0/32 (0%)h 50/55 (91%)g
West Africa (Etosha National Park) 0/66 (0%)i 0/66 (0%)i 44/66 (67%)i 2/66 (3%)i 0/66 (0%)j
a ELISA dOD .0.100.
b Hemagglutination titer .10.
c ELISA dOD .0.
d IFA titer $25.
eWestern blot positive (more data will be presented separately [35a]).
f p27 antigen ELISA.
gWestern blot positive (5).
h IFA titer 5 10 (43).
i IFA titer 5 10 (44).
j Recombinant p24 ELISA positive (45).
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the properties of the virus was given. Assuming that the sen-
sitivity and the specificity of the two assays are comparable, we
conclude that the prevalence of FCoV antibodies in East Af-
rica described here is indeed much higher than those in Kruger
National Park and Etosha National Park. That we indeed did
measure antibodies to FCoV is further supported by unpub-
lished PCR (14, 17) results from one of our laboratories (D.F.,
R.H.-L., H.L., Clinical Laboratory, Department of Internal
Veterinary Medicine, University of Zurich) in which we could
demonstrate the presence of a coronavirus in some of the lion
sera tested. Sequencing studies of this putative lion coronavi-
rus are underway.
The possible disease spectrum associated with FCoV in lions
is unknown. FCoV infection may not be of great importance to
the clinical health of the free-ranging lions as there was no
relationship between antibodies to FCoV and life expectancy.
Correlation between antibodies to FCoV and antibodies to
FIV. There was a strong correlation between antibodies to
FCoV and antibodies to FIV (Table 1). Such a correlation may
be due to similar modes of transmission of the viruses, al-
though this would be rather unexpected as in domestic cats
FCoV infection is readily transmitted by mere close contact
and does not require bites as in the case of FIV. Another
possibility to explain this correlation would be cross-reacting
antigens present in both virus preparations. Identical se-
quences of 5 to 10 amino acids have been found in infectious
agents as unrelated as plasmodium, human immunodeficiency
virus, and human influenza virus (28).
Demonstration of antibodies to FCV in free-ranging lions.
Antibodies to FCV were detectable by ELISA in 70% of all
lions. ELISA results were confirmed by IFA. Good accordance
was found between ELISA and IFA. To our knowledge, this is
the first evidence for the occurrence of antibodies specific for
FCV in free-ranging lions. No antibodies to FCV were re-
ported from lions in Kruger National Park or Etosha National
Park (43, 44).
The prevalence of antibodies to FCV increased with increas-
ing age of the lions (Fig. 3). In addition, the dOD measured by
ELISA also increased with increasing age. The increased prev-
alence may be a sign of de novo infection of uninfected ani-
mals. The increase in dOD may reflect an increase in affinity of
the FCV-specific antibodies in chronically infected or rein-
fected lions. ELISA procedures have been reported to detect
high-affinity antibodies readily (8, 21). The same phenomenon
of increased dOD with increasing age was also seen in the FHV
data obtained by ELISA.
Prevalence of antibodies to FCV in lions inhabiting different
habitats. Interestingly, high levels of antibody to FCV were
found almost exclusively in lions originating from Serengeti
National Park. Only very few animals from Ngorongoro Crater
and none of the lions from the Lake Manyara region had high
levels of antibody to FCV (Fig. 2, Table 3). Although these lion
habitats are adjacent (Fig. 1), a spreading of contagious infec-
tions must not necessarily be expected between the Serengeti
plains and Ngorongoro Crater. Ngorongoro Crater is a large
volcanic caldera surrounded by a suboptimal habitat for lions.
Therefore, only very limited emigration takes place, and no
immigration of lions into the crater has been recorded since
1965 (35). Moreover, there is no direct connection between
Lake Manyara National Park and Serengeti National Park.
Therefore no exchange of animals is expected. Another expla-
nation, but a rather unlikely one, is a decreased susceptibility
to FCV of lions from Ngorongoro Crater. The lions of Seren-
geti National Park and Ngorongoro Crater reflect populations
with quite different natural histories. Lions in Serengeti Na-
tional Park represent a large outbred population and reflect a
high level of genetic diversity, while lions from Ngorongoro
Crater have undergone a series of population bottlenecks (29,
30, 35, 52). It is not known whether this difference could ex-
plain a lower susceptibility to FCV in lions from Ngorongoro
Crater, or on the contrary, whether it would lead to increased
susceptibility, as has been reported in cheetahs for feline in-
fectious peritonitis (32).
Correlation between antibodies to FCV and antibodies to
other viruses. The occurrences of antibodies to FCV and an-
tibodies to FPV were strongly correlated (Table 2). While a
similar correlation between antibodies to FCV and antibodies
to FIV (Table 1) could be explained by an increased preva-
lence of the two infections with increasing age, this was not
the case with FCV and FPV. There are several other possible
explanations for this correlation, such as (i) cross-reactivity of
the two antigens, (ii) a similar mode of transmission of the two
viruses, and (iii) higher risk of some lions for FCV and/or FPV
infection due to certain risk factors, such as close contact with
other species which could transmit the viruses to the lion pop-
ulations. Of particular interest in this context could be close
contact with humans and domestic cats. As cross-reactivity of
antigens seems to be unlikely because different test principles
were used, the correlation may rather be due to a similar mode
of transmission or common risk factors.
Antibodies to FHV. Antibodies to FHV were found by
ELISA in all of the samples except one. A similar situation was
found in Etosha National Park and Kruger National Park, in
which 67% and 91% of the lions were positive, respectively (43,
44) (Table 3). In order to confirm this very high prevalence of
antibodies to FHV, 28 sera with low and high ELISA dODs
were also tested by IFA. All samples were IFA positive; titers
varied from 10 to 80 and corresponded well with the results
from ELISA. In addition, Western blot assays were estab-
lished, revealing protein bands characteristic for FHV (data
not shown). Different frequency distributions of the ELISA
dOD from lions of the different habitats were demonstrated.
The two peaks seen in Ngorongoro lions could be explained by
the fact that, in four prides, relatively high antibody levels were
present, while three other prides had low scores. It is striking
that the interpride variation was not a function of the year
sampled—samples were collected over several years—or of the
animals’ age. Therefore the high scores may not indicate epi-
demics at a specific time but could be due to different strains of
FHV or to differences in the immune reaction of the lions
involved.
Prevalence of antibodies to FPV in different habitats. Anti-
bodies to FPV were detectable in the hemagglutination inhi-
bition test in 68% of the samples tested (n 5 309). In domestic
cats postvaccination titers .160 were found to correlate with
protection. In the lion population, 55% of the animals tested
had a titer of 160 or higher. Whether this antibody titer in-
duced by natural infection corresponds with protection is not
known. Interestingly, the prevalence of high titers to FPV was
much higher in lions from Serengeti National Park than in
lions from Ngorongoro Crater (Fig. 4), suggesting an influence
of the habitat. As in the case of FCV, the essential absence of
FPV from lions of Ngorongoro Crater can be explained by the
virtual absence of immigration of lions into the crater. Fur-
thermore, the Serengeti plains are very rich in migratory prey
animals. Therefore, lions sometimes move over large distances
and thus encounter a greater number of other lions. This may
favor spread of FCV and FPV in this location.
A decline in titers was observed with increasing age of the
lions. In contrast to the ELISA system, as mentioned above for
FCV, the hemagglutination system yields a higher titer for a
serum with a low affinity but broader specificity than for a
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serum with a high affinity and a very narrow specificity for only
a few epitopes. Therefore, the decrease in titers with increasing
age of the lions may reflect an increase in the affinity of the lion
sera resulting from chronic infection or repeated reinfection.
Increased titers of antibodies to FPV in 1985 and 1986. It
became clear that during the observation period the frequen-
cies of titers to FPV fluctuated in the sera collected in
Serengeti National Park (Fig. 5). On the basis of the observa-
tion that the titers were increased in 1985 and 1986 and de-
clined thereafter, we speculated that a parvovirus outbreak
must have occurred, which seemed transient and self-limiting.
All samples from the Lake Manyara region were collected in
1987. Therefore, no follow-up over the years was possible in
that area. No such fluctuation was found in the samples from
Ngorongoro Crater, although interpretation was somewhat
limited by the small number of samples collected in 1985 and
1987. However, these data support the observation that al-
though the Serengeti plains and Ngorongoro Crater are adja-
cent, there was hardly any exchange of animals between these
habitats. Natural barriers found around Ngorongoro Crater
are able to protect animals from even highly contagious infec-
tions such as feline panleukopenia.
Pathogenic potential of FIV. The high prevalence of anti-
bodies to FIV (91 to 93%) in lion populations inhabiting Tan-
zania’s national parks came not as a surprise and confirms
earlier findings (6). The present study adds new information in
that the relationship between FIV and other infections can be
studied. This point has been discussed above. It also allows
speculation on the pathogenic potential of FIV in lions. If FIV
infection had a significant pathogenic potential, it might be
expected that coinfection with other viruses would lead to a
more rapid clinical progression and therefore to a lower mean
age of coinfected animals. As there was no difference in the
mean age of lions coinfected with FIV and FCV and with FIV
and FCoV (data not shown), it may be speculated that FIV in
lions has a low pathogenic potential (unpublished data) (41).
In addition, there was no apparent relationship between the
prevalence of antibodies to the five viruses and the survival of
the free-ranging lions. More information on the effect of FIV
infection on the health status and survival time will be pub-
lished elsewhere (35a). It could be speculated that the impact
of FCV, FPV, FHV, and FCoV infections on individual lions is
not very big and that these infections do not endanger the lion
populations, at least as long as there are no other aggravating
cofactors.
FeLV infection. So far, there are only rarely reports of FeLV
infection in wild felids, and most of them relate to captive
animals. Only two of them are in association with free-ranging
animals (4, 19). To our knowledge, this is the first systematic
investigation of the occurrence of FeLV antigen in serum of
free-ranging lions. From the fact that all of the samples were
FeLV negative, we conclude that FeLV infection does not play
a major role in free-ranging lions.
In conclusion, FCoV, FCV, FHV, FPV, and FIV, but not
FeLV, are endemic in free-ranging lions inhabiting Serengeti
National Park (Table 3). In addition, there is evidence for an
outbreak of FPV infection between 1985 and 1987. However,
the clinical relevance of this outbreak was probably minor, in
that no significant changes in the mortality of cubs was regis-
tered between 1985 and 1987. Lion populations of different
habitats in East Africa (Serengeti plains, Ngorongoro Crater,
the Lake Manyara region) host different viruses (Table 3, Fig.
1). Natural barriers that prevent the exchange of lions also
prevent the spread of even highly contagious infections such as
FPV infection. In addition, different prevalences of antiviral
antibodies were found in East African lions compared with
those of lions inhabiting Etosha National Park and Kruger
National Park (Table 3, Fig. 1). Therefore, dislocation of lions
by humans without consideration of the serological status
might be very dangerous and must be considered very care-
fully.
ACKNOWLEDGMENTS
This study was supported by the U.S. National Science Foundation
(grant numbers BSR-8507987, DBS-8807702, and IBN-9107397) and
the Union Bank of Switzerland on behalf of a customer.
We are indebted to S. Bolla, M. Gartmann, G. Konersmann, B.
Sigrist, and C. Wolfensberger for excellent technical assistance and to
M. Bryan for helping with the preparation of the manuscript. We thank
M. Appel for critically reviewing the manuscript and for helpful sug-
gestions.
REFERENCES
1. Barlough, J. E., J. C. Adsit, and F. W. Scott. 1982. The worldwide occurrence
of feline infectious peritonitis. Feline Pract. 12:26–30.
2. Barr, M. C., P. P. Calle, M. E. Roelke, and F. W. Scott. 1989. Feline
immunodeficiency virus infection in nondomestic felids. J. Zoo Wildl. Med
20:265–272.
3. Boever, W. J., S. McDonald, and R. F. Solorzano. 1977. Feline viral rhino-
tracheitis in a colony of clouded leopards. Vet. Med. Small Anim. Clin.
72:1859–1866.
4. Boid, R., S. McOrist, T. W. Jones, N. Easterbee, A. L. Hubbard, and O.
Jarrett. 1991. Isolation of FeLV from a wild felid (Felis silvestris). Vet. Rec.
128:256.
5. Brown, E. W., R. A. Olmsted, J. S. Martenson, and S. J. O’Brien. 1993.
Exposure to FIV and FIPV in wild and captive cheetahs. Zoo Biol. 12:135–
142.
6. Brown, E. W., N. Yuhki, C. Packer, and S. J. O’Brien. 1994. A lion lentivirus
related to feline immunodeficiency virus: epidemiologic and phylogenetic
aspects. J. Virol. 68:5953–5968.
7. Bu¨rki, F., B. Starustka, and O. Ruttner. 1976. Attempts to serologically
classify feline caliciviruses on a national and an international basis. Infect.
Immun. 14:876–881.
8. Callahan, L. T., III, A. F. Woodhour, J. B. Meeker, and M. R. Hilleman.
1979. Enzyme-linked immunosorbent assay for measurement of antibodies
against pneumococcal polysaccharide antigens: comparison with radioimmu-
noassay. J. Clin. Microbiol. 10:459–463.
9. Colby, E. D., and R. J. Low. 1970. Feline infectious peritonitis. Vet. Med.
Small Anim. Clin. 65:783–786.
10. Evermann, J. F., G. Burns, M. E. Roelke, A. J. McKeirnan, A. Greenlee, A. C.
Ward, and M. L. Pfeifer. 1983. Diagnostic features of an epizootic of feline
infectious peritonitis in captive cheetahs. Am. Assoc. Vet. Lab. Diagn. 26:
365–382.
11. Evermann, J. F., J. L. Heeney, A. J. McKeirnan, and S. J. O’Brien. 1989.
Comparative features of a coronavirus isolated from a cheetah with feline
infectious peritonitis. Virus Res. 13:15–27.
12. Evermann, J. F., J. L. Heeney, M. E. Roelke, A. J. McKeirnan, and S. J.
O’Brien. 1988. Biological and pathological consequences of feline infectious
peritonitis virus infection in the cheetah. Arch. Virol. 102:155–171.
13. Fargeaud, D., B. C. Jeannin, F. Kato, and G. Chappuis. 1984. Biochemical
study of feline herpesvirus 1 identification of glycoproteins by affinity. Arch.
Virol. 80:69–82.
14. Fehr, D., S. Bolla, A. A. P. M. Herrewegh, M. C. Horzinek, and H. Lutz. 1995.
Nachweis feliner Coronaviren mittels RT-PCR: Grundlage zum Studium der
Pathogenese der Felinen infektio¨sen Peritonitis (FIP). Schweiz. Arch. Tier-
heilkd. 138:74–79.
15. Hardy, W. D., Jr., and A. J. McClelland. 1977. Feline leukemia virus. Its
related diseases and control. Vet. Clin. North Am. 7:93–103.
16. Heeney, J. L., J. F. Evermann, A. J. McKeirnan, L. Marker-Kraus, M. E.
Roelke, M. Bush, D. E. Wildt, D. G. Meltzer, L. Colly, and J. Lukas. 1990.
Prevalence and implications of feline coronavirus infections of captive and
free-ranging cheetahs (Acinonyx jubatus). J. Virol. 64:1964–1972.
17. Herrewegh, A. A., R. J. de Groot, A. Cepica, H. F. Egberink, M. C. Horzinek,
and P. J. Rottier. 1995. Detection of feline coronavirus RNA in feces, tissues,
and body fluids of naturally infected cats by reverse transcriptase
PCR. J. Clin. Microbiol. 33:684–689.
18. Jarrett, W. F., E. M. Crawford, W. M. Martin, and F. Davie. 1964. A
virus-like particle associated with leukaemia (lymphosarcoma). Nature (Lon-
don) 202:567–568.
19. Jessup, D. A., K. C. Pettan, L. J. Lowenstine, and N. C. Pedersen. 1993.
Feline leukemia virus infection and renal spirochetosis in free-ranging cou-
gar (felis concolor). J. Zoo Wildl. Med 24:73–79.
20. Johnson, R. H. 1964. Isolation of a virus from a condition simulating feline
panleucopaenia in a leopard. Vet. Rec. 76:1008–1013.
VOL. 3, 1996 VIRUS SEROLOGY OF LIONS IN EAST AFRICA 561
 o
n
 February 3, 2016 by NO
VA SO
UTHEASTERN UNIV
http://cvi.asm
.org/
D
ow
nloaded from
 
21. Lehtonen, O. P., and O. H. Meurman. 1982. An ELISA for the estimation of
high-avidity and total specific IgG and IgM antibodies to rubella virus.
J. Virol. Methods 5:1–10.
22. Letcher, J. D., and T. P. O’Conner. 1991. Incidence of antibodies reacting to
FIV in a population of Asiatic lions. J. Zoo Wildl. Med. 22:324–329.
23. Lutz, H., P. Arnold, U. Hubscher, H. Egberink, N. Pedersen, and M. C.
Horzinek. 1988. Specificity assessment of feline T-lymphotropic lentivirus
serology. Zentralbl. Veterinaermed. Reihe B 35:773–778.
24. Lutz, H., B. Hauser, and M. Horzinek. 1984. Die Diagnostik der felinen
infektio¨sen Peritonitis mittels der Serologie. Prakt. Tierarzt 5:406–407.
25. Lutz, H., E. Isenbugel, R. Lehmann, R. H. Sabapara, and C. Wolfensberger.
1992. Retrovirus infections in non-domestic felids: serological studies and
attempts to isolate a lentivirus. Vet. Immunol. Immunopathol. 35:215–224.
26. Lutz, H., N. Pedersen, J. Higgins, U. Hubscher, F. A. Troy, and G. H.
Theilen. 1980. Humoral immune reactivity to feline leukemia virus and
associated antigens in cats naturally infected with feline leukemia virus.
Cancer Res. 40:3642–3651.
27. Lutz, H., N. C. Pedersen, R. Durbin, and G. H. Theilen. 1983. Monoclonal
antibodies to three epitopic regions of feline leukemia virus p27 and their
use in enzyme-linked immunosorbent assay of p27. J. Immunol. Methods
56:209–220.
28. McLaughlin, G. L., M. J. Benedik, and G. H. Campbell. 1987. Repeated
immunogenic amino acid sequences of Plasmodium species share sequence
homologies with proteins from humans and human viruses. Am. J. Trop.
Med. Hyg. 37:258–262.
29. O’Brien, S. J., and J. F. Evermann. 1988. Interactive influence of infectious
disease and genetic diversity in natural populations. Trends Ecol. Evol.
3:254–259.
30. O’Brien, S. J., J. S. Martenson, C. Packer, L. Herbst, V. de Vos, P. Joslin, J.
Ott-Joslin, D. E. Wildt, and M. Bush. 1987. Biochemical genetic variation in
geographic isolates of African and Asiatic lions. Natl. Geogr. Res. 3:114–124.
31. O’Brien, S. J., M. E. Roelke, L. Marker, A. Newman, C. A. Winkler, D.
Meltzer, L. Colly, J. F. Evermann, M. Bush, and D. E. Wildt. 1985. Genetic
basis for species vulnerability in the cheetah. Science 227:1428–1434.
32. O’Brien, S. J., D. E. Wildt, D. Goldman, C. R. Merril, and M. Bush. 1983.
The cheetah is depauperate in genetic variation. Science 221:459–462.
33. Olmsted, R. A., R. Langley, M. E. Roelke, R. M. Goeken, D. Adger-Johnson,
J. P. Goff, J. P. Albert, C. Packer, M. K. Laurenson, and T. M. Caro. 1992.
Worldwide prevalence of lentivirus infection in wild feline species: epidemi-
ologic and phylogenetic aspects. J. Virol. 66:6008–6018.
34. Osterhaus, A. D., M. C. Horzinek, and D. J. Reynolds. 1977. Seroepidemi-
ology of feline infectious peritonitis virus infections using transmissible gas-
troenteritis virus as antigen. Zentralbl. Veterinaermed. Reihe B 24:835–841.
35. Packer, C., A. E. Pusey, H. Rowley, D. A. Gilbert, J. Martenson, and S. J.
O’Brien. 1991. Case study of a population bottleneck: lions of the Ngor-
ongoro Crater. Conserv. Biol. 5:219–230.
35a.Packer, C., et al. Unpublished data.
36. Paul-Murphy, J., T. Work, D. Hunter, E. McFie, and D. Fjelline. 1994.
Serologic survey and serum biochemical reference ranges of the free-ranging
mountain lion (Felis concolor) in California. J. Wildl. Dis. 30:205–215.
37. Pedersen, N. C. 1983. Feline infectious peritonitis and feline enteric coro-
navirus infections. Part 2. Feline infectious peritonitis. Feline Pract. 13:5–20.
38. Pfeifer, M. L., J. F. Evermann, M. E. Roelke, A. M. Gallina, R. L. Ott, and
A. J. McKeirnan. 1983. Feline infectious peritonitis in a captive cheetah. J.
Am. Vet. Med. Assoc. 183:1317–1319.
39. Poelma, F. G., J. C. Peters, W. H. W. Mieog, and P. Zwart. 1974. Infektio¨se
Peritonitis bei Krakal (Felis Caracal) und Nordluchs (Felis Lynx Lynx), p.
249–253. In Erkankungen der Zootiere, 13th International Symposium of
Zoo Veterinarians, Helsinki, Finland.
40. Quesenberry, K. E. 1984. Infectious diseases of nondomestic cats. Vet. Clin.
North Am. Small Anim. Pract. 14:1089–1106.
41. Roelke-Parker, M. E., L. Munson, C. Packer, R. Kock, S. Cleaveland, M.
Carpenter, S. J. O’Brien, A. Pospischil, R. Hofmann-Lehmann, H. Lutz,
G. L. M. Mwamengele, M. N. Mgasa, G. A. Machange, B. A. Summers, and
M. J. G. Appel. 1996. A canine distemper virus epidemic in Serengeti lions
(panthera leo). Nature (London) 379:441–445.
42. Specter, S., and G. J. Lancz. 1986. Clinical virology manual, p. 203. Elsevier
Scientific Publishers, New York.
43. Spencer, J. A. 1991. Survey of antibodies to feline viruses in free-ranging
lions. South-Afr. J. Wildl. Res. 21:59–61.
44. Spencer, J. A., and P. Morkel. 1993. Serological survey of sera from lions in
Etosha National Park. S.-Afr. Tydskr. Natuurnav. 23:60–61.
45. Spencer, J. A., A. A. Van Dijk, M. C. Horzinek, H. F. Egberink, R. G. Bengis,
D. F. Keet, S. Morikawa, and D. H. Bishop. 1992. Incidence of feline im-
munodeficiency virus reactive antibodies in free-ranging lions of the Kruger
National Park and the Etosha National Park in southern Africa detected by
recombinant FIV p24 antigen. Onderstepoort J. Vet. Res. 59:315–322.
46. Studdert, M. J., C. M. Kelly, and K. E. Harrigan. 1973. Isolation of panleu-
copaenia virus from lions. Vet. Rec. 93:156–158.
47. Theobald, J. 1978. Felidae, p. 650–667. In M. E. Fowler (ed.), Zoo and wild
animal medicine. W.B. Saunders Co., Philadelphia.
48. Thompson, N. L., M. Sabine, and R. H. Hyne. 1971. Herpesviruses isolated
from cheetahs. Aust. Vet. J. 47:458–459.
49. Truyen, U., N. Stockhofe-Zurwieden, O. R. Kaaden, and J. Pohlenz. 1990. A
case report: encephalitis in lions. Pathological and virological findings.
Dtsch. Tieraerztl. Wochenschr. 97:89–91.
50. Tuch, K., K. H. Witte, and H. Wuller. 1974. Diagnosis of feline infectious
peritonitis (FIP) in domestic cats and leopards in Germany. Zentralbl. Vet-
erinaermed. Reihe B 21:426–441. (In German.)
51. Van Rensburg, I. B., and M. A. Silkstone. 1984. Concomitant feline infec-
tious peritonitis and toxoplasmosis in a cheetah (Acinonyx jubatus). J. S. Afr.
Vet. Assoc. 55:205–207.
52. Wildt, D. E., M. Bush, K. L. Goodrowe, C. Packer, A. E. Pusey, J. L. Brown,
P. Joslin, and S. J. O’Brien. 1987. Reproductive and genetic consequences of
founding isolated lion populations. Nature (London) 329:328–331.
53. Worley, M. 1987. Feline coronavirus, p. 431–436. InM. J. Appel (ed.), Virus
infections of carnivores. Elsevier Science Publishers, New York.
562 HOFMANN-LEHMANN ET AL. CLIN. DIAGN. LAB. IMMUNOL.
 o
n
 February 3, 2016 by NO
VA SO
UTHEASTERN UNIV
http://cvi.asm
.org/
D
ow
nloaded from
 
